Adam Koppel - Dec 2, 2022 Form 3 Insider Report for Solid Biosciences Inc. (SLDB)

Signature
/s/ Adam Koppel
Stock symbol
SLDB
Transactions as of
Dec 2, 2022
Transactions value $
$0
Form type
3
Date filed
12/5/2022, 03:58 PM
Previous filing
Jun 22, 2022
Next filing
Dec 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLDB Common Stock 3.13M Dec 2, 2022 See footnotes F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's Common Stock held by BCLS SB Investco, LP ("BCLS SB"), Bain Capital Life Sciences Fund II, L.P. ("BCLS Fund II"), BCLS II Investco, LP ("BCLS II Investco") and BCIP Life Sciences Associates, LP ("BCIPLS" and, together with BCLS SB, BCLS Fund II and BCLS II Investco, the "Bain Capital Life Sciences Entities").
F2 Dr. Koppel is a Managing Director of Bain Capital Life Sciences Investors, LLC ("BCLSI"). BCLSI (i) is the ultimate general partner of each of BCLS SB, BCLS Fund II and BCLS II Investco and (ii) governs the investment strategy and decision-making process with respect to investments held by BCIPLS. As a result, Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Life Sciences Entities. Dr. Koppel disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.